A Clinical Study of Dushivisaari Agad and Ark Tail in Vicharchika (Atopic dermatitis).
Trial Snapshot
- Phase
- Phase 1/2
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- LFT
Study Overview
Brief Summary
STUDY DESIGN
· Typesof study - Openlabelled clinical trial with single group.
· Level of study - O.P.D. & I.P.D. UPGIAS&R, DSRRAU JODHPUR and other registeredhospital
· Number of groups - One
· Sample size - 30
· Primary purpose - Efficacy and safety
· End point - Therapy
DRUGAND POSOLOGY
| Patient |
30
Treatment Modality
Dose
Duration
|Dushivisaari Agad
3gms BD with honey
30 Days
|Ark Tail
For local application.
30 Days
FOLLOW UP STUDY
· After completion of thetrial, the case will be followed every 15 days interval for 30 days.
· Improvement and other effect will be noted.
· Laboratoryinvestigations will be repeated if seemed necessary
Study Design
- Study Type
- Interventional
- Allocation
- Not Applicable
- Masking
- Open Label
Eligibility Criteria
- Ages
- 18.00 Year(s) to 50.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Diagnosed Patient complaints having itching,.
- •2.Age between 18-50 year.
- •3.Patient willing to give consent for clinical trial.
Exclusion Criteria
- •1.Endocrine disorder like diabetes mallitus, thyroid disfunction.
- •2.Age- below18 years and above 50 years.
- •3.patients who are suffering from major psychiatric disorder.
Outcomes
Primary Outcomes
LFT
Time Frame: 30 days
Improvement in the values of following data
Time Frame: 30 days
CBC
Time Frame: 30 days
blood sugar random
Time Frame: 30 days
ESR
Time Frame: 30 days
KFT
Time Frame: 30 days
Secondary Outcomes
- improvement in sign & symptoms like Kandu (itching)(Srava (discharge))